Welcome to our Impact Report for 2022–2023, a snapshot of one of the charity’s most successful years so far.
There has been a lot to be proud of, from our largest ever investment in sarcoma research (£1.3 million) to the doubling of our vital Support Line capacity. We’ve increased our information and resources to patients and healthcare professionals and stepped up our advocacy work on behalf of sarcoma patients and their families. Our achievements have only been possible through greater engagement and partnership with the sarcoma community.
A commitment to collaboration runs through the DNA of Sarcoma UK and its aspirations and we continue to maximise this in every aspect of our work. As we set our course for the second half of our five-year strategy, we are determined to do even more. Our ambitions have only become a reality thanks to you and your support, in every shape and form. When we have experienced challenges, you have helped us beat them.
This report demonstrates just what we can achieve together and how we can work to transform the lives of everyone affected by sarcoma.
Richard Davidson
Chief Executive of Sarcoma UK
